2. Studies on the Multiplication of Chkunya Virus (CHV), and on Physical and Chemical Structure of Its Virion
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Eisai Announces Results and Continued Support Of
No.17-18 April 19, 2017 Eisai Co., Ltd. EISAI ANNOUNCES RESULTS AND CONTINUED SUPPORT OF INITIATIVES FOR ELIMINATION OF LYMPHATIC FILARIASIS 5 YEAR ANNIVERSARY OF LONDON DECLARATION ON NEGLECTED TROPICAL DISEASES Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) has announced the results of its initiatives for the elimination of lymphatic filariasis (LF), and its continued support of this cause in the future. This announcement was made at an event held in Geneva, Switzerland, on April 18, marking the 5th anniversary of the London Declaration on Neglected Tropical Diseases (NTDs), an international public-private partnership. Announced in January 2012, the London Declaration is the largest public-private partnership in the field of global health, and represents a coordinated effort by global pharmaceutical companies, the Bill & Melinda Gates Foundation, the World Health Organization (WHO), the United States, United Kingdom and NTD-endemic country governments, as well as other partners, to eliminate 10 NTDs by the year 2020. Since the signing of the London Declaration, donations of medical treatments by pharmaceutical companies have increased by 70 percent, and these treatments contribute to the prevention and cure of disease in approximately 1 billion people every year. Under the London Declaration, Eisai signed an agreement with WHO to supply 2.2 billion high-quality diethylcarbamazine (DEC) tablets, which were running in short supply worldwide, at Price Zero (free of charge) by the year 2020. These DEC tablets are manufactured at Eisai’s Vizag Plant in India. As of the end of March 2017, 1 billion tablets have been supplied to 27 endemic countries. -
Pathophysiology and Gastrointestinal Impacts of Parasitic Helminths in Human Being
Research and Reviews on Healthcare: Open Access Journal DOI: 10.32474/RRHOAJ.2020.06.000226 ISSN: 2637-6679 Research Article Pathophysiology and Gastrointestinal Impacts of Parasitic Helminths in Human Being Firew Admasu Hailu1*, Geremew Tafesse1 and Tsion Admasu Hailu2 1Dilla University, College of Natural and Computational Sciences, Department of Biology, Dilla, Ethiopia 2Addis Ababa Medical and Business College, Addis Ababa, Ethiopia *Corresponding author: Firew Admasu Hailu, Dilla University, College of Natural and Computational Sciences, Department of Biology, Dilla, Ethiopia Received: November 05, 2020 Published: November 20, 2020 Abstract Introduction: This study mainly focus on the major pathologic manifestations of human gastrointestinal impacts of parasitic worms. Background: Helminthes and protozoan are human parasites that can infect gastrointestinal tract of humans beings and reside in intestinal wall. Protozoans are one celled microscopic, able to multiply in humans, contributes to their survival, permits serious infections, use one of the four main modes of transmission (direct, fecal-oral, vector-borne, and predator-prey) and also helminthes are necked multicellular organisms, referred as intestinal worms even though not all helminthes reside in intestines. However, in their adult form, helminthes cannot multiply in humans and able to survive in mammalian host for many years due to their ability to manipulate immune response. Objectives: The objectives of this study is to assess the main pathophysiology and gastrointestinal impacts of parasitic worms in human being. Methods: Both primary and secondary data were collected using direct observation, books and articles, and also analyzed quantitativelyResults and and conclusion: qualitatively Parasites following are standard organisms scientific living temporarily methods. in or on other organisms called host like human and other animals. -
The Immunology of Filariasis*
Articles in the Update series Les articles de la rubrique give a concise, authoritative, Le point fournissent un and up-to-date survey of the bilan concis et fiable de la present position in the se- situation actuelle dans le a e lected fields, and, over a domaine considere. Des ex- ,,v period of years, will cover / perts couvriront ainsi suc- / many different aspects of cessivement de nombreux the biomedical sciences aspects des sciences bio- e nVlfo l l gZ / / and public health. Most of medicales et de la sante the articles will be writ- publique. La plupart de ces ten, by invitation, by ac- articles auront donc ee knowledged experts on the rediges sur demande par les subject. specialistes les plus autorises. Bulletin of the World Health Organization, 59 (1): 1-8 (1981) The immunology of filariasis* SCIENTIFIC WORKING GROUP ON FILARIASIS1 This report summarizes the available information on the immunology of filariasis, and discusses immunodiagnosis and the immunologicalfactors influencing the host-parasite relationship in lymphaticfilariasis and onchocerciasis. Severalareas that requirefurther research are identifed, particularly concerning the development of new serological techniques, and the fractionation of specific antigens. The problems associated with vaccine development are considered and the importance of finding better animal modelsfor research is stressed. Lymphatic filariasis and onchocerciasis are recognized as important public health problems in many tropical and subtropical areas. However, until recently, little was known about the natural history of filariasis or the immune mechanisms involved. This report summarizes current knowledge on various aspects of the immunology of the disease and outlines areas for future research. -
1 Summary of the Thirteenth Meeting of the ITFDE (II) October 29, 2008
Summary of the Thirteenth Meeting of the ITFDE (II) October 29, 2008 The Thirteenth Meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center from 8:30am to 4:00 pm on October 29, 2008. Topics discussed at this meeting were the status of the global campaigns to eliminate lymphatic filariasis (LF) and to eradicate dracunculiasis (Guinea worm disease), an update on efforts to eliminate malaria and LF from the Caribbean island of Hispaniola (Dominican Republic and Haiti), and a report on the First Program Review for Buruli ulcer programs. The Task Force members are Dr. Olusoji Adeyi, The World Bank; Sir George Alleyne, Johns Hopkins University; Dr. Julie Gerberding, Centers for Disease Control and Prevention (CDC); Dr. Donald Hopkins, The Carter Center (Chair); Dr. Adetokunbo Lucas, Harvard University; Professor David Molyneux, Liverpool School of Tropical Medicine (Rtd.); Dr. Mark Rosenberg, Task Force for Child Survival and Development; Dr. Peter Salama, UNICEF; Dr. Lorenzo Savioli, World Health Organization (WHO); Dr. Harrison Spencer, Association of Schools of Public Health; Dr. Dyann Wirth, Harvard School of Public Health, and Dr. Yoichi Yamagata, Japan International Cooperation Agency (JICA). Four of the Task Force members (Hopkins, Adeyi, Lucas, Rosenberg) attended this meeting, and three others were represented by alternates (Dr. Stephen Blount for Gerberding, Dr. Mark Young for Dr. Salama, Dr. Dirk Engels for Savioli). Presenters at this meeting were Dr. Eric Ottesen of the Task Force for Child Survival and Development, Dr. Patrick Lammie of the CDC, Dr. Ernesto Ruiz-Tiben of The Carter Center, Dr. David Joa Espinal of the National Center for Tropical Disease Control (CENCET) in the Dominican Republic, and Dr. -
Toxocariasis: Visceral Larva Migrans in Children Toxocaríase: Larva Migrans Visceral Em Crianças E Adolescentes
0021-7557/11/87-02/100 Jornal de Pediatria Copyright © 2011 by Sociedade Brasileira de Pediatria ARTIGO DE REVISÃO Toxocariasis: visceral larva migrans in children Toxocaríase: larva migrans visceral em crianças e adolescentes Elaine A. A. Carvalho1, Regina L. Rocha2 Resumo Abstract Objetivos: Apresentar investigação detalhada de fatores de risco, Objectives: To present a detailed investigation of risk factors, sintomatologia, exames laboratoriais e de imagem que possam contribuir symptoms, and laboratory and imaging tests that may be useful to para o diagnóstico clínico-laboratorial da larva migrans visceral (LMV) em establish the clinical laboratory diagnosis of visceral larva migrans (VLM) crianças e mostrar a importância do diagnóstico e do tratamento para in children, demonstrating the importance of diagnosis and treatment to evitar complicações oculares, hepáticas e em outros órgãos. prevent complications in the eyes, liver, and other organs. Fontes dos dados: Revisão de literatura utilizando os bancos de Sources: Literature review using the MEDLINE and LILACS (1952- dados MEDLINE e LILACS (1952-2009), selecionando os artigos mais 2009) databases, selecting the most recent and representative articles atuais e representativos do tema. on the topic. Síntese dos dados: LMV é uma doença infecciosa de apresentação Summary of the findings: VLM is an infectious disease with non- clínica inespecífica cuja transmissão está relacionada ao contato com cães, specific clinical presentation, whose transmission is related to contact principalmente filhotes, podendo evoluir com complicações sistêmicas with dogs, especially puppies, and which may progress to late systemic tardias em órgãos vitais como o olho e sistema nervoso central. Para complications in vital organs such as the eyes and the central nervous diagnóstico laboratorial, pode ser utilizado IgG (ELISA) anti-Toxocara system. -
Developing Vaccines to Combat Hookworm Infection and Intestinal Schistosomiasis
REVIEWS Developing vaccines to combat hookworm infection and intestinal schistosomiasis Peter J. Hotez*, Jeffrey M. Bethony*‡, David J. Diemert*‡, Mark Pearson§ and Alex Loukas§ Abstract | Hookworm infection and schistosomiasis rank among the most important health problems in developing countries. Both cause anaemia and malnutrition, and schistosomiasis also results in substantial intestinal, liver and genitourinary pathology. In sub-Saharan Africa and Brazil, co-infections with the hookworm, Necator americanus, and the intestinal schistosome, Schistosoma mansoni, are common. The development of vaccines for these infections could substantially reduce the global disability associated with these helminthiases. New genomic, proteomic, immunological and X-ray crystallographic data have led to the discovery of several promising candidate vaccine antigens. Here, we describe recent progress in this field and the rationale for vaccine development. In terms of their global health impact on children and that combat hookworm and schistosomiasis, with an pregnant women, as well as on adults engaged in subsist- emphasis on disease caused by Necator americanus, the ence farming, human hookworm infection (known as major hookworm of humans, and Schistosoma mansoni, ‘hookworm’) and schistosomiasis are two of the most the primary cause of intestinal schistosomiasis. common and important human infections1,2. Together, their disease burdens exceed those of all other neglected Global distribution and pathobiology tropical diseases3–6. They also trap the world’s poorest Hookworms are roundworm parasites that belong to people in poverty because of their deleterious effects the phylum Nematoda. They share phylogenetic simi- on child development and economic productivity7–9. larities with the free-living nematode Caenorhabditis Until recently, the importance of these conditions as elegans and with the parasitic nematodes Nippostrongylus global health and economic problems had been under- brasiliensis and Heligmosomoides polygyrus, which are appreciated. -
Parasites in Liver & Biliary Tree
Parasites in Liver & Biliary tree Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition University of Louisville & Louisville VAMC 2011 Parasites in Liver & Biliary Tree Hepatic Biliary Tree • Protozoa • Protozoa – E. histolytica – Cryptosporidiasis – Malaria – Microsporidiasis – Babesiosis – Isosporidiasis – African Trypanosomiasis – Protothecosis – S. American Trypanosomiasis • Trematodes – Visceral Leishmaniasis – Fascioliasis – Toxoplasmosis – Clonorchiasis • Cestodes – Opistorchiasis – Echynococcosis • Nematodes • Trematodes – Ascariasis – Schistosomiasis • Nematodes – Toxocariasis – Hepatic Capillariasis – Strongyloidiasis – Filariasis Parasites in the Liver Entamoeba histolytica • Organism: E. histolytica is a Protozoa Sarcodina that infects 1‐ 5% of world population and causes 100000 deaths/y. – (E. dispar & E. moshkovskii are morphologically identical but only commensal; PCR or ELISA in stool needed to differentiate). • Distribution: worldwide; more in tropics and areas with poor sanitation. • Location: colonic lumen; may invade crypts and capillaries. More in cecum, ascending, and sigmoid. • Forms: trophozoites (20 mcm) or cysts (10‐20 mcm). Erytrophagocytosis is diagnostic for E. histolytica trophozoite. • Virulence: may increase with immunosuppressant drugs, malnutrition, burns, pregnancy and puerperium. Entamoeba histolytica • Clinical forms: – I) asymptomatic; – II) symptomatic: • A. Intestinal: – a) Dysenteric, – b) Nondysenteric colitis. • B. Extraintestinal: – a) Hepatic: i) acute -
Neglected Tropical Diseases: Epidemiology and Global Burden
Tropical Medicine and Infectious Disease Review Neglected Tropical Diseases: Epidemiology and Global Burden Amal K. Mitra * and Anthony R. Mawson Department of Epidemiology and Biostatistics, School of Public Health, Jackson State University, Jackson, PO Box 17038, MS 39213, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-601-979-8788 Received: 21 June 2017; Accepted: 2 August 2017; Published: 5 August 2017 Abstract: More than a billion people—one-sixth of the world’s population, mostly in developing countries—are infected with one or more of the neglected tropical diseases (NTDs). Several national and international programs (e.g., the World Health Organization’s Global NTD Programs, the Centers for Disease Control and Prevention’s Global NTD Program, the United States Global Health Initiative, the United States Agency for International Development’s NTD Program, and others) are focusing on NTDs, and fighting to control or eliminate them. This review identifies the risk factors of major NTDs, and describes the global burden of the diseases in terms of disability-adjusted life years (DALYs). Keywords: epidemiology; risk factors; global burden; DALYs; NTDs 1. Introduction Neglected tropical diseases (NTDs) are a group of bacterial, parasitic, viral, and fungal infections that are prevalent in many of the tropical and sub-tropical developing countries where poverty is rampant. According to a World Bank study, 51% of the population of sub-Saharan Africa, a major focus for NTDs, lives on less than US$1.25 per day, and 73% of the population lives on less than US$2 per day [1]. In the 2010 Global Burden of Disease Study, NTDs accounted for 26.06 million disability-adjusted life years (DALYs) (95% confidence interval: 20.30, 35.12) [2]. -
Lymphatic Filariasis: Elimination in the Americas
Lymphatic Filariasis: Elimination in the Americas Center for Global Health Division of Parasitic Diseases and Malaria The Burden of Lymphatic Filariasis (LF) To date, close to 700 million people in some of the poorest areas globally have received treatment to prevent one of the world’s most incapacitating diseases, lymphatic filariasis. ymphatic filariasis (LF) is a disabling parasitic disease caused Lby microscopic worms that are spread from person-to-person by the bite of an infected mosquito. The adult worms live in the human lymphatic system and can cause lymphedema (swelling) affecting the legs, arms, or breasts. They can also cause hydrocele (severe fluid accumulation) affecting the genitalia of men. Chronic manifestations of lymphatic filariasis, which usually take place years after initial infection, can cause pain, severe and irreversible disfigurement, and stigmatization. Lymphatic filariasis is one of the world’s neglected tropical diseases (NTDs), a group of infectious diseases affecting more than 1 billion people that is responsible for tremendous suffering and economic loss. LF is recognized as one of the most disabling and economically costly NTDs, as infection with the disease can lead to lower productivity and inability to work. Over 120 million persons are infected with LF, a disease that can be eliminated In 2000, the World Health Organization launched The Global Programme to Eliminate Lymphatic Filariasis, with a target elimination date of 2020. This initiative is driven by a two-fold strategy to interrupt the spread of infection and reduce the suffering of persons already infected. These efforts to interrupt transmission and improve disease management ensure that future generations will not suffer the same disability. -
Infection with Mansonella Perstans Nematodes in Buruli Ulcer Patients
DISPATCHES infection in mice by biting (4), but it is not clear that this is Infection with the cause of human infection (5). In southeastern Australia, evidence has been found linking infected mosquitoes with Mansonella human cases (6,7), but proof of transmission is lacking. Residents of regions in which Buruli ulcer is endemic perstans are frequently exposed to parasitic infections such as fila- Nematodes in riasis. In Ghana, lymphatic filariasis caused byWuchereria bancrofti nematodes is found in several regions to which Buruli Ulcer Buruli ulcer is endemic, such as the Upper Denkyira Dis- trict in the central region of Ghana, but its prevalence is Patients, Ghana unknown (8). The filarial nematode Mansonella perstans is endemic to countries in central and western Africa; its Richard O. Phillips, Michael Frimpong, distribution overlaps that of other filarial nematodes W. Fred S. Sarfo, Birte Kretschmer, bancrofti, Loa loa, and Onchocerca volvulus (9). Infec- Marcus Beissner, Alexander Debrah, tive M. perstans larvae are transmitted through the bite of Yaw Ampem-Amoako, Kabiru M. Abass, Culicoides midges (Diptera: Ceratopogonidae); the larvae William Thompson, Mabel Sarpong Duah, develop over the course of months into adult worms that Justice Abotsi, Ohene Adjei, Bernhard Fleischer, reside in serous cavities, particularly in the abdomen. M. Gisela Bretzel, Mark Wansbrough-Jones, perstans infection is not associated with a specific set of and Marc Jacobsen clinical signs and symptoms, but those attributed to this in- fection include acute swelling in the forearms, hands, and During August 2010–December 2012, we conducted a study of patients in Ghana who had Buruli ulcer, caused face that recedes in a few days and often recurs; itching by Mycobacterium ulcerans, and found that 23% were co- with or without rash; arthralgia; and eosinophilia (9). -
Interruption of Lymphatic Filariasis Transmission in Manaus, a Former Focus of Wuchereria 18 Bancrofti in the Western Brazilian Amazon
01 Pan American Journal Original research of Public Health 02 03 04 05 06 Interruption of lymphatic filariasis transmission in 07 08 Manaus, a former focus of Wuchereria bancrofti in the 09 10 Western Brazilian Amazon 11 12 13 Marilaine Martins,1 Rebeca Cristina Souza Guimarães,2 and Gilberto Fontes3 14 15 16 17 Suggested citation Martins M, Guimarães RCS, Fontes G. Interruption of lymphatic filariasis transmission in Manaus, a former focus of Wuchereria 18 bancrofti in the Western Brazilian Amazon. Rev Panam Salud Publica. 2021;45:e1. https://doi.org/10.26633/RPSP.2021.1 19 20 21 22 ABSTRACT Objective. To confirm the absence of Wuchereria bancrofti autochthonous cases in Manaus, a former focus of 23 lymphatic filariasis in the Western Brazilian Amazon. 24 Methods. A field survey was carried out in 2016 using immunochromatographic rapid tests (ICT card) for the 25 detection of circulating filarial antigens in blood. The sample included a group of 3 000 schoolchildren aged 6 26 to 10 years enrolled in schools from different urban areas of Manaus (including the former lymphatic filariasis 27 focus in the city) and a group of 709 adolescents and adults, between the ages of 11 and 85 years, born and 28 raised in different areas of Manaus. 29 Results. All of the individuals tested negative for W. bancrofti antigen. 30 Conclusions. Although Manaus was once considered endemic, this focus no longer seems to be active for 31 lymphatic filariasis transmission. The results of this study could support the certification by the World Health 32 Organization of the lymphatic filariasis transmission elimination exercise in Brazil. -
Eliminating Lymphatic Filariasis, Onchocerciasis, and Schistosomiasis from the Americas: Breaking a Historical Legacy of Slavery
Historical Profiles and Perspectives Eliminating Lymphatic Filariasis, Onchocerciasis, and Schistosomiasis from the Americas: Breaking a Historical Legacy of Slavery Patrick J. Lammie1*, John F. Lindo2,3, W. Evan Secor1, Javier Vasquez2, Steven K. Ault2, Mark L. Eberhard1 1 Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America, 2 Pan American Health Organization/World Health Organization, Washington, D. C., United States of America, 3 The University of the West Indies, Kingston, Jamaica The 2007 bicentennial of the enactment velopment in the United States and in the pleting the interruption of transmission in of the bill to abolish the transatlantic slave Caribbean led to the spontaneous disap- the remaining active foci must now be trade in the British Empire has focused pearance of LF in some areas and sub- validated [10]. new attention on the historical legacy of stantial declines in the prevalence of 2007 also marks the centenary of the slavery and its human and social con- infection in others [7]. Ongoing trans- first description of Schistosoma mansoni, the sequences. Beyond the societal impact of mission in the Western Hemisphere, now causative agent of schistosomiasis in slavery, which continues to the present limited to four countries (Brazil, the the Americas. Schistosomiasis was once day, the transportation of millions of Dominican Republic, Haiti, and Guyana), widespread throughout the Caribbean and persons from sub-Saharan Africa to the is concentrated in impoverished settings South America and was a major cause of New World also resulted in the importa- and appears to be a growing problem in hepatic fibrosis and death.